Crystal Genomics identified that 'Polmacoxib' has effect for preventing and curing colon cancer
New drug development bio-venture company, Crystal Genomics identified that their new degenerative arthritis treatment 'Polmacoxib' of which they applied new drug application (NDA) in May, has effect for preventing and curing colon cancer.
The result of study was published in the August 3 issue o...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
